99 related articles for article (PubMed ID: 26947351)
1. Optimization of a UDP-glucuronosyltransferase assay for trout liver S9 fractions: activity enhancement by alamethicin, a pore-forming peptide.
Ladd MA; Fitzsimmons PN; Nichols JW
Xenobiotica; 2016 Dec; 46(12):1066-1075. PubMed ID: 26947351
[TBL] [Abstract][Full Text] [Related]
2. ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT.
Ishii Y; An K; Nishimura Y; Yamada H
Drug Metab Dispos; 2012 Nov; 40(11):2081-9. PubMed ID: 22851616
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Activation of rat liver microsomal UDP-glucuronosyltransferase activity by alamethicin.
Little JM; Lehman PA; Nowell S; Samokyszyn V; Radominska A
Drug Metab Dispos; 1997 Jan; 25(1):5-11. PubMed ID: 9010623
[TBL] [Abstract][Full Text] [Related]
4. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells.
Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M
Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of UDP-glucuronosyltransferase activity in sea turtle
Dias VHV; Mattos JJ; Bastolla CLV; Lüchmann KH; Bainy ACD
Xenobiotica; 2022 Dec; 52(12):1011-1019. PubMed ID: 36594659
[TBL] [Abstract][Full Text] [Related]
6. The effects of UDP-sugars, UDP and Mg
Walia G; Smith AD; Riches Z; Collier AC; Coughtrie MWH
Xenobiotica; 2018 Sep; 48(9):882-890. PubMed ID: 28868965
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
[TBL] [Abstract][Full Text] [Related]
8. 4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms.
Al-Zoughool M; Talaska G
J Appl Toxicol; 2006; 26(6):524-32. PubMed ID: 17080401
[TBL] [Abstract][Full Text] [Related]
9. Adenine-related compounds modulate UDP-glucuronosyltransferase (UGT) activity in mouse liver microsomes.
Nakamura S; Yamashita R; Miyauchi Y; Tanaka Y; Ishii Y
Xenobiotica; 2021 Nov; 51(11):1247-1254. PubMed ID: 34727004
[TBL] [Abstract][Full Text] [Related]
10. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the intraluminal positioning of p-nitrophenol UDP-glucuronosyltransferase activity in rat liver microsomal vesicles.
Fulceri R; Bánhegyi G; Gamberucci A; Giunti R; Mandl J; Benedetti A
Arch Biochem Biophys; 1994 Feb; 309(1):43-6. PubMed ID: 8117111
[TBL] [Abstract][Full Text] [Related]
12. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
13. Latency is the major determinant of UDP-glucuronosyltransferase activity in isolated hepatocytes.
Bánhegyi G; Garzó T; Fulceri R; Benedetti A; Mandl J
FEBS Lett; 1993 Aug; 328(1-2):149-52. PubMed ID: 8393805
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.
Cubitt HE; Houston JB; Galetin A
Pharm Res; 2009 May; 26(5):1073-83. PubMed ID: 19184618
[TBL] [Abstract][Full Text] [Related]
15. Metabolic assessment in liver microsomes by co-activating cytochrome P450s and UDP-glycosyltransferases.
Yan Z; Caldwell GW
Eur J Drug Metab Pharmacokinet; 2003; 28(3):223-32. PubMed ID: 14527096
[TBL] [Abstract][Full Text] [Related]
16. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions.
Visser TJ; Kaptein E; van Toor H; van Raaij JA; van den Berg KJ; Joe CT; van Engelen JG; Brouwer A
Endocrinology; 1993 Nov; 133(5):2177-86. PubMed ID: 8404669
[TBL] [Abstract][Full Text] [Related]
18. Development of a microplate method for the determination of hepatic UDP-glucuronosyltransferase activity in rainbow trout (Oncorhynchus mykiss) and Nile tilapia (Oreochromis niloticus).
Hooft JM; Lou Y; Squires EJ; Cant JP; Bureau DP
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Oct; 248():109114. PubMed ID: 34147683
[TBL] [Abstract][Full Text] [Related]
19. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements.
Mazur CS; Kenneke JF; Hess-Wilson JK; Lipscomb JC
Drug Metab Dispos; 2010 Dec; 38(12):2232-8. PubMed ID: 20736320
[TBL] [Abstract][Full Text] [Related]
20. Optimal assay conditions for liver UDP-glucuronosyltransferase from the rainbow trout, Salmo gairdneri.
Castrén M; Oikari A
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 76(2):365-9. PubMed ID: 6140121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
